108 related articles for article (PubMed ID: 25211518)
21. Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation.
Novoa-Takara L; Perkins SL; Qi D; Shidham VB; Vesole DH; Hariharan S; Luo Y; Ewton A; Chang CC
Am J Clin Pathol; 2005 Jan; 123(1):104-12. PubMed ID: 15762285
[TBL] [Abstract][Full Text] [Related]
22. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
[TBL] [Abstract][Full Text] [Related]
23. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
[TBL] [Abstract][Full Text] [Related]
24. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU
Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349
[TBL] [Abstract][Full Text] [Related]
25. Primary central nervous system posttransplant lymphoproliferative disorders.
Castellano-Sanchez AA; Li S; Qian J; Lagoo A; Weir E; Brat DJ
Am J Clin Pathol; 2004 Feb; 121(2):246-53. PubMed ID: 14983939
[TBL] [Abstract][Full Text] [Related]
26. High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder.
Saito H; Miyoshi H; Shibayama H; Toda J; Kusakabe S; Ichii M; Fujita J; Fukushima K; Maeda T; Mizuki M; Oritani K; Seto M; Yokota T; Kanakura Y; Hosen N; Ohshima K
Int J Hematol; 2021 Jul; 114(1):53-64. PubMed ID: 33765256
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
Birkeland SA; Hamilton-Dutoit S; Bendtzen K
Transplantation; 2003 Jul; 76(1):153-8. PubMed ID: 12865802
[TBL] [Abstract][Full Text] [Related]
28. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.
Abu-Elmagd KM; Mazariegos G; Costa G; Soltys K; Bond G; Sindhi R; Green M; Jaffe R; Wu T; Koritsky D; Matarese L; Schuster B; Martin L; Dvorchik I; Nalesnik MA
Transplantation; 2009 Oct; 88(7):926-34. PubMed ID: 19935465
[TBL] [Abstract][Full Text] [Related]
29. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
30. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
[TBL] [Abstract][Full Text] [Related]
31. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
[TBL] [Abstract][Full Text] [Related]
32. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
Ghobrial IM; Habermann TM; Maurer MJ; Geyer SM; Ristow KM; Larson TS; Walker RC; Ansell SM; Macon WR; Gores GG; Stegall MD; McGregor CG
J Clin Oncol; 2005 Oct; 23(30):7574-82. PubMed ID: 16186599
[TBL] [Abstract][Full Text] [Related]
33. Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders.
Kinch A; Baecklund E; Molin D; Pauksens K; Sundström C; Tufveson G; Enblad G
Acta Oncol; 2021 Jun; 60(6):771-778. PubMed ID: 33793378
[No Abstract] [Full Text] [Related]
34. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618
[TBL] [Abstract][Full Text] [Related]
35. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J
Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
[TBL] [Abstract][Full Text] [Related]
36. Simian virus 40 in posttransplant lymphoproliferative disorders.
Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
[TBL] [Abstract][Full Text] [Related]
37. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
38. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
39. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
[TBL] [Abstract][Full Text] [Related]
40. The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection.
Krustrup D; Madsen CB; Iversen M; Engelholm L; Ryder LP; Andersen CB
Transpl Immunol; 2013 Dec; 29(1-4):71-5. PubMed ID: 23969200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
